Maternal immunity to insulin does not affect diabetes risk in progeny of non obese diabetic mice

Clinical and Experimental Immunology

Volumn 136, Issue 1, 2004, Pages 56-59

  Koczwara, K ^a   Ziegler, A G ^a   Bonifacio, E ^a,b,c  

^a Klinikum Schwabing   (Germany)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

Author keywords

Autoimmune diabetes; Insulin antibodies; Maternal antibodies

Indexed keywords

AUTOANTIBODY; GLUCAGON; INSULIN; INSULIN ANTIBODY; MATERNAL ANTIBODY;

ANIMAL MODEL; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETIC PREDISPOSITION; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; NEWBORN; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT; RISK FACTOR;

ANIMALS; AUTOANTIBODIES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMALE; IMMUNITY, MATERNALLY-ACQUIRED; INSULIN; INSULIN ANTIBODIES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 1842611820     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02406.x     Document Type: Article

References (18)

1. Zinkernagel RM. Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med 2001; 345:1331-5.
2. Kenny JF, Pangburn PC, Trail G. Effect of estradiol on immune competence: in vivo and in vitro studies. Infect Immun 1976; 13:448-56.
3. Clerici E, Bergamasco E, Ferrario E, Villa ML. Influence of sex steroids on the antigen-specific primary antibody response in vitro. J Clin Laboratory Immunol 1991; 34:71-8.
4. McKeever U, Khandekar S, Newcomb J et al. Immunization with soluble BDC 2.5 T cell receptor-immunoglobulin chimeric protein: antibody specificity and protection of nonobese diabetic mice against adoptive transfer of diabetes by maternal immunization. J Exp Med 1996; 184:1755-68.
5. Greeley SA, Katsumata M, YuL et al. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 2002; 8:399-402.
6. Koczwara K, Schenker M, Schmid S, Kredel K, Ziegler AG, Bonifacio E. Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse. Clin Immunol 2003; 106:155-62.
7. Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E, Singh B. International Workshop on Lessons from Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 2001; 50:2451-8.
8. Manca F, Kunkl A, Fenoglio D, Fowler A, Sercarz E, Celada F. Constraints in T-B coorperation related to epitope topology on E. coli beta-galactosidase. I. The fine specificity of T cells dictates the fine specificity of antibodies directed to conformation-dependent determinants. Eur J Immunol 1985; 15:345-50.
9. Manca F, Fenoglio D, Kunkl A, Cambiaggi C, Sasso M, Celada F. Differential activation of T cell clones stimulated by macrophages exposed to antigen comlexed with monoclonal antibodies. A possible influence of paratope specificity on the mode of antigen processing. J Immunol 1988; 140:2893-8.
10. Lin RH, Mamula MJ, Hardin JA, Janeway CA Jr. Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med 1991; 173:1433-9.
11. Watts C, Lanzavecchia A. Suppressive effect of antibody on processing of T cell epitopes. J Exp Med 1993; 178:1459-63.
12. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med 1995; 181:1957-63.
13. Noorchashm H, Noorchashm N, Kern J, Rostami SY, Barker CF, Naji A. B-cells are required for the initiation of insulitis in nonobese diabetic mice. Diabetes 1997; 46:941-6.
14. Martin S, Wolf-Eichbaum D, Duinkerken G, Scherbaum WA, Kolb H, Noordzij JG, Roep BO. Develpoment of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 2001; 345:1036-40.
15. Fosgren S, Andersson A, Hillron V, Soderstrom A, Holmberg D. Immunoglobulin-mediated prevention of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Scand J Immunol 1991; 34:445-51.
16. null mice. J Exp Med 1996; 184:2049-53.
17. Akashi T, Nagafuchi S, Anzai K et al. Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int Immunol 1997; 9:1159-64.
18. Silveira PA, Johnson E, Chapman HD, Bui T, Tisch RM, Serreze DV. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur J Immunol 2002; 32:3657-66.